NCT00067626View on ClinicalTrials.gov

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
ObesityPre-diabetesInsulin ResistanceImpaired Glucose ToleranceImpaired Fasting Glucose
Interventions
DIETARY_SUPPLEMENT

Chromium

500/1000 mcg oral chromium picolinate taken daily or placebo (crossover)

Trial Locations (1)

06418

Yale-Griffin Prevention Research Center, Derby

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Yale University

OTHER

lead

Griffin Hospital

OTHER

NCT00067626 - Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes | Biotech Hunter | Biotech Hunter